Clinical Evaluation and Diagnosis
ShareCompartir
- Clinical Guidance on the Identification and Evaluation of Possible SARS-CoV Disease among Persons Presenting with Community-Acquired Illness Version 2 (Jan 8, 2004)
- In the Absence of SARS-CoV Transmission Worldwide: Guidance for Surveillance, Clinical and Laboratory Evaluation, and Reporting Version 2 (Jan 21, 2004)
- Specimen Testing and Diagnosis
- Guidelines for Laboratory Diagnosis of SARS-CoV Infection (Jan 8, 2004)
Appendix F8, Supplement Fof Public Health Guidance for Community-Level Preparedness and Response to SARS - Guidelines for Clinicians: The Consent Process for SARS-CoV RT-PCR and EIA Testing at CDC and Public Health Laboratories (Jan 8, 2004)
Appendix F3, Supplement F of Public Health Guidance for Community-Level Preparedness and Response to SARS - Guidelines for Collecting Specimens from Potential SARS Patients (Jan 8, 2004)
Appendix F4, Supplement F of Public Health Guidance for Community-Level Preparedness and Response to SARS - Fact Sheet for Clinicians: Interpreting SARS-CoV Test Results from CDC and Other Public Health Laboratories (Jan 8, 2004)
Appendix F7, Supplement F of Public Health Guidance for Community-Level Preparedness and Response to SARS
- Guidelines for Laboratory Diagnosis of SARS-CoV Infection (Jan 8, 2004)
- Informed Consent for Laboratory Testing
- Page last reviewed: December 15, 2011
- Page last updated: December 15, 2011
- Content source: